{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:08:18Z","timestamp":1788566898596,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"crossref","award":["NRCT5-RGJ63003-055"],"award-info":[{"award-number":["NRCT5-RGJ63003-055"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Fundamental Fund of Khon Kaen University, under the National Science, Research and Inovation Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-024-04610-2","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T13:02:38Z","timestamp":1725022958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cannabidiol exhibits potent anti-cancer activity against gemcitabine-resistant cholangiocarcinoma via ER-stress induction in vitro and in vivo"],"prefix":"10.1186","volume":"24","author":[{"given":"Thatsanapong","family":"Pongking","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phonpilas","family":"Thongpon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitti","family":"Intuyod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirinapha","family":"Klungsaeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raynoo","family":"Thanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apisit","family":"Chaidee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naruechar","family":"Charoenram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suppakrit","family":"Kongsintaweesuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadamas","family":"Sakonsinsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulthida","family":"Vaeteewoottacharn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somchai","family":"Pinlaor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Porntip","family":"Pinlaor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"issue":"9","key":"4610_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388. https:\/\/doi.org\/10.1038\/s41575-020-0310-z.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"4610_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13(5):261\u201380. https:\/\/doi.org\/10.1038\/nrgastro.2016.51.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"4610_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","volume":"39","author":"SA Khan","year":"2019","unstructured":"Khan SA, Tavolari S, Brandi G, Cholangiocarcinoma. Epidemiology and risk factors. Liver Int. 2019;39(Suppl 1):19\u201331. https:\/\/doi.org\/10.1111\/liv.14095.","journal-title":"Liver Int"},{"issue":"1","key":"4610_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.7314\/apjcp.2016.17.1.401","volume":"17","author":"V Luvira","year":"2016","unstructured":"Luvira V, Nilprapha K, Bhudhisawasdi V, Pugkhem A, Chamadol N, Kamsa-ard S. Cholangiocarcinoma patient outcome in northeastern Thailand: single-center prospective study. Asian Pac J Cancer Prev. 2016;17(1):401\u20136. https:\/\/doi.org\/10.7314\/apjcp.2016.17.1.401.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"11","key":"4610_CR5","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.7314\/apjcp.2012.14.11.7029","volume":"14","author":"N Thunyaharn","year":"2013","unstructured":"Thunyaharn N, Promthet S, Wiangnon S, Suwanrungruang K, Kamsa-ard S. Survival of cholangiocarcinoma patients in northeastern Thailand after supportive treatment. Asian Pac J Cancer Prev. 2013;14(11):7029\u201332. https:\/\/doi.org\/10.7314\/apjcp.2012.14.11.7029.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"4610_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11894-017-0542-4","volume":"19","author":"B Doherty","year":"2017","unstructured":"Doherty B, Nambudiri VE, Palmer WC. Update on the diagnosis and treatment of cholangiocarcinoma. Curr Gastroenterol Rep. 2017;19(1):2. https:\/\/doi.org\/10.1007\/s11894-017-0542-4.","journal-title":"Curr Gastroenterol Rep"},{"issue":"14","key":"4610_CR7","first-page":"4417","volume":"50","author":"LW Hertel","year":"1990","unstructured":"Hertel LW, Boder GB, Kroin JS, Rinzel SM, Poore GA, Todd GC, et al. Evaluation of the antitumor activity of gemcitabine (2\u2019,2\u2019-difluoro-2\u2019-deoxycytidine). Cancer Res. 1990;50(14):4417\u201322.","journal-title":"Cancer Res"},{"key":"4610_CR8","doi-asserted-by":"publisher","first-page":"106006","DOI":"10.1016\/j.intimp.2019.106006","volume":"78","author":"N Sawasdee","year":"2020","unstructured":"Sawasdee N, Thepmalee C, Sujjitjoon J, Yongpitakwattana P, Junking M, Poungvarin N, et al. Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells. Int Immunopharmacol. 2020;78:106006. https:\/\/doi.org\/10.1016\/j.intimp.2019.106006.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"4610_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jpba.2005.01.047","volume":"38","author":"R Martino","year":"2005","unstructured":"Martino R, Gilard V, Desmoulin F, Malet-Martino M. Fluorine-19 or phosphorus-31 NMR spectroscopy: a suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs. J Pharm Biomed Anal. 2005;38(5):871\u201391. https:\/\/doi.org\/10.1016\/j.jpba.2005.01.047.","journal-title":"J Pharm Biomed Anal"},{"issue":"20","key":"4610_CR10","doi-asserted-by":"publisher","first-page":"9510","DOI":"10.1158\/0008-5472.CAN-05-0989","volume":"65","author":"AM Bergman","year":"2005","unstructured":"Bergman AM, Eijk PP, van Ruiz VW, Smid K, Veerman G, Hubeek I, et al. In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant. Cancer Res. 2005;65(20):9510\u20136. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0989.","journal-title":"Cancer Res"},{"issue":"4 Suppl 11","key":"4610_CR11","first-page":"19","volume":"22","author":"P Huang","year":"1995","unstructured":"Huang P, Plunkett W. Induction of apoptosis by gemcitabine. Semin Oncol. 1995;22(4 Suppl 11):19\u201325.","journal-title":"Semin Oncol"},{"issue":"11","key":"4610_CR12","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1038\/sj.bjc.6605377","volume":"101","author":"AD Wagner","year":"2009","unstructured":"Wagner AD, Buechner-Steudel P, Moehler M, Schmalenberg H, Behrens R, Fahlke J, et al. Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials. Br J Cancer. 2009;101(11):1846\u201352. https:\/\/doi.org\/10.1038\/sj.bjc.6605377.","journal-title":"Br J Cancer"},{"issue":"10","key":"4610_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","volume":"13","author":"C Holohan","year":"2013","unstructured":"Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013;13(10):714\u201326. https:\/\/doi.org\/10.1038\/nrc3599.","journal-title":"Nat Rev Cancer"},{"issue":"4 Pt B","key":"4610_CR14","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.bbadis.2017.06.005","volume":"1864","author":"JJG Marin","year":"2018","unstructured":"Marin JJG, Lozano E, Herraez E, Asensio M, Di Giacomo S, Romero MR, et al. Chemoresistance and chemosensitization in cholangiocarcinoma. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4 Pt B):1444\u201353. https:\/\/doi.org\/10.1016\/j.bbadis.2017.06.005.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4610_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jbior.2017.11.007","volume":"68","author":"A Adamska","year":"2018","unstructured":"Adamska A, Elaskalani O, Emmanouilidi A, Kim M, Abdol Razak NB, Metharom P, et al. Molecular and cellular mechanisms of chemoresistance in pancreatic cancer. Adv Biol Regul. 2018;68:77\u201387. https:\/\/doi.org\/10.1016\/j.jbior.2017.11.007.","journal-title":"Adv Biol Regul"},{"issue":"3","key":"4610_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.tranon.2018.12.004","volume":"12","author":"US Kosgodage","year":"2019","unstructured":"Kosgodage US, Uysal-Onganer P, MacLatchy A, Mould R, Nunn AV, Guy GW, et al. Cannabidiol affects extracellular vesicle release, miR21 and miR126, and reduces rrohibitin protein in glioblastoma multiforme cells. Transl Oncol. 2019;12(3):513\u201322. https:\/\/doi.org\/10.1016\/j.tranon.2018.12.004.","journal-title":"Transl Oncol"},{"key":"4610_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jss.2018.08.055","volume":"235","author":"E Simmerman","year":"2019","unstructured":"Simmerman E, Qin X, Yu JC, Baban B. Cannabinoids as a potential new and novel treatment for melanoma: a pilot study in a murine model. J Surg Res. 2019;235:210\u20135. https:\/\/doi.org\/10.1016\/j.jss.2018.08.055.","journal-title":"J Surg Res"},{"key":"4610_CR18","doi-asserted-by":"publisher","first-page":"697832","DOI":"10.3389\/fcell.2021.697832","volume":"9","author":"F Shangguan","year":"2021","unstructured":"Shangguan F, Zhou H, Ma N, Wu S, Huang H, Jin G, et al. A novel mechanism of cannabidiol in suppressing hepatocellular carcinoma by inducing GSDME dependent pyroptosis. Front Cell Dev Biol. 2021;9:697832. https:\/\/doi.org\/10.3389\/fcell.2021.697832.","journal-title":"Front Cell Dev Biol"},{"key":"4610_CR19","doi-asserted-by":"publisher","unstructured":"Hamad H, Olsen BB. Cannabidiol induces cell death in human lung cancer cells and cancer stem cells. Pharmaceuticals (Basel). 2021;14(11). https:\/\/doi.org\/10.3390\/ph14111169.","DOI":"10.3390\/ph14111169"},{"key":"4610_CR20","doi-asserted-by":"publisher","unstructured":"Almeida CF, Teixeira N, Correia-da-Silva G, Amaral C. Cannabinoids in breast cancer: Differential susceptibility according to subtype. Molecules. 2021;27(1). https:\/\/doi.org\/10.3390\/molecules27010156.","DOI":"10.3390\/molecules27010156"},{"key":"4610_CR21","doi-asserted-by":"publisher","unstructured":"Zhang X, Qin Y, Pan Z, Li M, Liu X, Chen X, et al. Cannabidiol induces cell cycle arrest and cell apoptosis in human gastric cancer sgc-7901 cells. Biomolecules. 2019;9(8). https:\/\/doi.org\/10.3390\/biom9080302.","DOI":"10.3390\/biom9080302"},{"issue":"1","key":"4610_CR22","doi-asserted-by":"publisher","first-page":"20622","DOI":"10.1038\/s41598-020-77674-y","volume":"10","author":"YY Go","year":"2020","unstructured":"Go YY, Kim SR, Kim DY, Chae SW, Song JJ. Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020;10(1):20622. https:\/\/doi.org\/10.1038\/s41598-020-77674-y.","journal-title":"Sci Rep"},{"key":"4610_CR23","doi-asserted-by":"publisher","unstructured":"Misri S, Kaul K, Mishra S, Charan M, Verma AK, Barr MP, et al. Cannabidiol inhibits tumorigenesis in cisplatin-resistant non-small cell lung cancer via TRPV2. Cancers (Basel). 2022;14(5). https:\/\/doi.org\/10.3390\/cancers14051181.","DOI":"10.3390\/cancers14051181"},{"key":"4610_CR24","doi-asserted-by":"publisher","unstructured":"Viereckl MJ, Krutsinger K, Apawu A, Gu J, Cardona B, Barratt D, et al. Cannabidiol and cannabigerol inhibit cholangiocarcinoma growth in vitro via divergent cell death pathways. Biomolecules. 2022;12(6). https:\/\/doi.org\/10.3390\/biom12060854.","DOI":"10.3390\/biom12060854"},{"issue":"6","key":"4610_CR25","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1038\/cddis.2011.52","volume":"2","author":"MP Lim","year":"2011","unstructured":"Lim MP, Devi LA, Rozenfeld R. Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis. Cell Death Dis. 2011;2(6):e170. https:\/\/doi.org\/10.1038\/cddis.2011.52.","journal-title":"Cell Death Dis"},{"issue":"5","key":"4610_CR26","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/jci37948","volume":"119","author":"M Salazar","year":"2009","unstructured":"Salazar M, Carracedo A, Salanueva IJ, Hernandez-Tiedra S, Lorente M, Egia A, et al. Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest. 2009;119(5):1359\u201372. https:\/\/doi.org\/10.1172\/jci37948.","journal-title":"J Clin Invest"},{"issue":"3","key":"4610_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s13577-020-00334-w","volume":"33","author":"B Sripa","year":"2020","unstructured":"Sripa B, Seubwai W, Vaeteewoottacharn K, Sawanyawisuth K, Silsirivanit A, Kaewkong W, et al. Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient. Hum Cell. 2020;33(3):695\u2013708. https:\/\/doi.org\/10.1007\/s13577-020-00334-w.","journal-title":"Hum Cell"},{"key":"4610_CR28","doi-asserted-by":"publisher","unstructured":"Phonpilas, Thongpon Kitti, Intuyod Sasitorn, Chomwong Thatsanapong, Pongking Sirinapha, Klungsaeng Kanha, et al. Curcumin synergistically enhances the efficacy of gemcitabine against gemcitabine-resistant cholangiocarcinoma via the targeting LAT2\/glutamine pathway. Sci Rep. 2024;14(1). https:\/\/doi.org\/10.1038\/s41598-024-66945-7.","DOI":"10.1038\/s41598-024-66945-7"},{"issue":"17","key":"4610_CR29","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1016\/j.biomaterials.2012.02.062","volume":"33","author":"D Liu","year":"2012","unstructured":"Liu D, Liu S, Jing X, Li X, Li W, Huang Y. Necrosis of cervical carcinoma by dichloroacetate released from electrospun polylactide mats. Biomaterials. 2012;33(17):4362\u20139. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.02.062.","journal-title":"Biomaterials"},{"key":"4610_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fpls.2016.00019","volume":"7","author":"CM Andre","year":"2016","unstructured":"Andre CM, Hausman JF, Guerriero G. Cannabis sativa: the plant of the thousand and one molecules. Front Plant Sci. 2016;7:19. https:\/\/doi.org\/10.3389\/fpls.2016.00019.","journal-title":"Front Plant Sci"},{"issue":"2","key":"4610_CR31","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.3747\/co.23.2962","volume":"23","author":"SK Aggarwal","year":"2016","unstructured":"Aggarwal SK. Use of cannabinoids in cancer care: palliative care. Curr Oncol. 2016;23(2):S33\u20136. https:\/\/doi.org\/10.3747\/co.23.2962.","journal-title":"Curr Oncol"},{"key":"4610_CR32","doi-asserted-by":"publisher","unstructured":"Kicman A, Toczek M. The effects of cannabidiol, a non-intoxicating compound of cannabis, on the cardiovascular system in health and disease. Int J Mol Sci. 2020;21(18). https:\/\/doi.org\/10.3390\/ijms21186740.","DOI":"10.3390\/ijms21186740"},{"issue":"1","key":"4610_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12906-021-03204-6","volume":"21","author":"F Hosami","year":"2021","unstructured":"Hosami F, Manayi A, Salimi V, Khodakhah F, Nourbakhsh M, Nakstad B, et al. The pro-apoptosis effects of Echinacea purpurea and Cannabis sativa extracts in human lung cancer cells through caspase-dependent pathway. BMC Complement Med Ther. 2021;21(1):37. https:\/\/doi.org\/10.1186\/s12906-021-03204-6.","journal-title":"BMC Complement Med Ther"},{"issue":"5","key":"4610_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.pbj.2017.07.109","volume":"2","author":"C Almeida","year":"2017","unstructured":"Almeida C, Augusto T, Correia-da-Silva G, Teixeira N, Amaral C. The effects of cannabinoids in exemestane-resistant breast cancer cells: PS181. Porto Biomed J. 2017;2(5):221\u20132. https:\/\/doi.org\/10.1016\/j.pbj.2017.07.109.","journal-title":"Porto Biomed J"},{"issue":"1","key":"4610_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cas.15609","volume":"114","author":"Y Yamamoto","year":"2023","unstructured":"Yamamoto Y, Kasashima H, Fukui Y, Tsujio G, Yashiro M, Maeda K. The heterogeneity of cancer-associated fibroblast subpopulations: their origins, biomarkers, and roles in the tumor microenvironment. Cancer Sci. 2023;114(1):16\u201324. https:\/\/doi.org\/10.1111\/cas.15609.","journal-title":"Cancer Sci"},{"issue":"9","key":"4610_CR36","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1021\/acs.jnatprod.3c00363","volume":"86","author":"E O\u2019Reilly","year":"2023","unstructured":"O\u2019Reilly E, Khalifa K, Cosgrave J, Azam H, Prencipe M, Simpson JC, et al. Cannabidiol inhibits the proliferation and invasiveness of prostate cancer cells. J Nat Prod. 2023;86(9):2151\u201361. https:\/\/doi.org\/10.1021\/acs.jnatprod.3c00363.","journal-title":"J Nat Prod"},{"issue":"1","key":"4610_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1124\/jpet.116.236968","volume":"360","author":"L Deng","year":"2017","unstructured":"Deng L, Ng L, Ozawa T, Stella N. Quantitative analyses of synergistic responses between cannabidiol and dna-damaging agents on the proliferation and viability of glioblastoma and neural progenitor cells in culture. J Pharmacol Exp Ther. 2017;360(1):215\u201324. https:\/\/doi.org\/10.1124\/jpet.116.236968.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"4610_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/157488611798280924","volume":"6","author":"MM Bergamaschi","year":"2011","unstructured":"Bergamaschi MM, Queiroz RH, Zuardi AW, Crippa JA. Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf. 2011;6(4):237\u201349. https:\/\/doi.org\/10.2174\/157488611798280924.","journal-title":"Curr Drug Saf"},{"key":"4610_CR39","doi-asserted-by":"publisher","first-page":"725136","DOI":"10.3389\/fphar.2021.725136","volume":"12","author":"C Gross","year":"2021","unstructured":"Gross C, Ramirez DA, McGrath S, Gustafson DL. Cannabidiol induces apoptosis and perturbs mitochondrial function in human and canine glioma cells. Front Pharmacol. 2021;12:725136. https:\/\/doi.org\/10.3389\/fphar.2021.725136.","journal-title":"Front Pharmacol"},{"key":"4610_CR40","doi-asserted-by":"publisher","unstructured":"Jeon Y, Kim T, Kwon H, Kim JK, Park YT, Ham J, et al. Cannabidiol enhances cabozantinib-induced apoptotic cell death via phosphorylation of p53 regulated by er stress in hepatocellular carcinoma. Cancers (Basel). 2023;15(15). https:\/\/doi.org\/10.3390\/cancers15153987.","DOI":"10.3390\/cancers15153987"},{"issue":"2","key":"4610_CR41","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/bab.2119","volume":"69","author":"A de la Harpe","year":"2022","unstructured":"de la Harpe A, Beukes N, Frost CL. CBD activation of TRPV1 induces oxidative signaling and subsequent ER stress in breast cancer cell lines. Biotechnol Appl Biochem. 2022;69(2):420\u201330. https:\/\/doi.org\/10.1002\/bab.2119.","journal-title":"Biotechnol Appl Biochem"},{"key":"4610_CR42","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.3389\/fimmu.2018.03083","volume":"9","author":"H Hu","year":"2018","unstructured":"Hu H, Tian M, Ding C, Yu S. The C\/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Front Immunol. 2018;9:3083. https:\/\/doi.org\/10.3389\/fimmu.2018.03083.","journal-title":"Front Immunol"},{"issue":"1","key":"4610_CR43","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41420-023-01578-9","volume":"9","author":"F Wang","year":"2023","unstructured":"Wang F, Dezfouli AB, Khosravi M, Sievert W, Stangl S, Schwab M, et al. Cannabidiol-induced crosstalk of apoptosis and macroautophagy in colorectal cancer cells involves p53 and Hsp70. Cell Death Discov. 2023;9(1):286. https:\/\/doi.org\/10.1038\/s41420-023-01578-9.","journal-title":"Cell Death Discov"},{"key":"4610_CR44","doi-asserted-by":"publisher","unstructured":"Schoeman R, Beukes N, Frost C. Cannabinoid combination induces cytoplasmic vacuolation in MCF-7 breast cancer cells. Molecules. 2020;25(20). https:\/\/doi.org\/10.3390\/molecules25204682.","DOI":"10.3390\/molecules25204682"},{"issue":"16","key":"4610_CR45","doi-asserted-by":"publisher","first-page":"13761","DOI":"10.1074\/jbc.M111123200","volume":"277","author":"K Barnouin","year":"2002","unstructured":"Barnouin K, Dubuisson ML, Child ES, Fernandez de Mattos S, Glassford J, Medema RH, et al. H. Induces Transient multi-phase cell Cycle Arrest Mouse Fibroblasts through Modulating Cyclin D p21Cip1 Expression J Biol Chem. 2002;277(16):13761\u201370. https:\/\/doi.org\/10.1074\/jbc.M111123200.","journal-title":"Induces Transient multi-phase cell Cycle Arrest Mouse Fibroblasts through Modulating Cyclin D p21Cip1 Expression J Biol Chem"},{"issue":"8","key":"4610_CR46","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1002\/ptr.6669","volume":"34","author":"JH Lin","year":"2020","unstructured":"Lin JH, Chen SY, Lu CC, Lin JA, Yen GC. Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells. Phytother Res. 2020;34(8):2053\u201366. https:\/\/doi.org\/10.1002\/ptr.6669.","journal-title":"Phytother Res"},{"key":"4610_CR47","doi-asserted-by":"publisher","unstructured":"Garcia-Morales L, Mendoza-Rodriguez MG, Tapia Ramirez J, Meza I. CBD inhibits in vivo development of human breast cancer tumors. Int J Mol Sci. 2023;24(17). https:\/\/doi.org\/10.3390\/ijms241713235.","DOI":"10.3390\/ijms241713235"},{"key":"4610_CR48","doi-asserted-by":"publisher","first-page":"867575","DOI":"10.3389\/fvets.2022.867575","volume":"9","author":"S Sakarin","year":"2022","unstructured":"Sakarin S, Meesiripan N, Sangrajrang S, Suwanpidokkul N, Prayakprom P, Bodhibukkana C, et al. Antitumor effects of cannabinoids in human pancreatic ductal adenocarcinoma cell line (Capan-2)-derived xenograft mouse model. Front Vet Sci. 2022;9:867575. https:\/\/doi.org\/10.3389\/fvets.2022.867575.","journal-title":"Front Vet Sci"},{"issue":"1","key":"4610_CR49","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1186\/s12885-023-11542-6","volume":"23","author":"S Tang","year":"2023","unstructured":"Tang S, Li S, Tang B, Wang X, Xiao Y, Cheke RA. Hormetic and synergistic effects of cancer treatments revealed by modelling combinations of radio - or chemotherapy with immunotherapy. BMC Cancer. 2023;23(1):1040. https:\/\/doi.org\/10.1186\/s12885-023-11542-6.","journal-title":"BMC Cancer"},{"key":"4610_CR50","doi-asserted-by":"publisher","unstructured":"Bondy SC. The Hormesis Concept: strengths and shortcomings. Biomolecules. 2023;13(10). https:\/\/doi.org\/10.3390\/biom13101512.","DOI":"10.3390\/biom13101512"},{"issue":"3","key":"4610_CR51","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/1091581810363012","volume":"29","author":"EL Kendig","year":"2010","unstructured":"Kendig EL, Le HH, Belcher SM. Defining hormesis: evaluation of a complex concentration response phenomenon. Int J Toxicol. 2010;29(3):235\u201346. https:\/\/doi.org\/10.1177\/1091581810363012.","journal-title":"Int J Toxicol"},{"issue":"7","key":"4610_CR52","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s00213-018-4885-9","volume":"235","author":"DL Boggs","year":"2018","unstructured":"Boggs DL, Surti T, Gupta A, Gupta S, Niciu M, Pittman B, et al. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial. Psychopharmacology. 2018;235(7):1923\u201332. https:\/\/doi.org\/10.1007\/s00213-018-4885-9.","journal-title":"Psychopharmacology"},{"issue":"1","key":"4610_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/can.2016.0034","volume":"2","author":"K Iffland","year":"2017","unstructured":"Iffland K, Grotenhermen F. An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies. Cannabis Cannabinoid Res. 2017;2(1):139\u201354. https:\/\/doi.org\/10.1089\/can.2016.0034.","journal-title":"Cannabis Cannabinoid Res"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-024-04610-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-024-04610-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-024-04610-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T13:03:05Z","timestamp":1725022985000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-024-04610-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4610"],"URL":"https:\/\/doi.org\/10.1186\/s12906-024-04610-2","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"6 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of study in CCA cell lines was approved by Khon Kaen University Ethics Committee for Human Research based on the declaration of Helsinki and the ICH good clinical practice guidelines (HE661473). Animal experiments were conducted following the Animal Ethics Committee of Khon Kaen University and the National Research Council of Thailand\u2019s guidelines (No. IACUC-KKU-62\/65). All methods are reported in accordance with ARRIVE guidelines for the reporting of animal experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"325"}}